Abstract
Caveolae are flask-shaped invaginations of the plasma membrane that are present in most structural cells. They owe their characteristic Ω-shape to complexes of unique proteins, the caveolins, which indirectly tether cholesterol and sphingolipid-enriched membrane microdomains to the cytoskeleton. Caveolins possess a unique scaffolding domain that anchors receptors, ion channels, second messenger producing enzymes, and effector kinases, thereby sequestering them to caveolae, and modulating cellular signaling and vesicular transport. The lungs express numerous caveolae and high levels of caveolins; therefore they likely play an important role in lung physiology. Indeed, recent and ongoing studies indicate important roles for caveolae and caveolins in the airway epithelium, airway smooth muscle, airway fibroblasts, airway inflammatory cells and the pulmonary vasculature. We review the role of caveolae and caveolins in lung cells and discuss their involvement in cellular signaling associated with asthma, COPD, lung cancer, idiopathic pulmonary fibrosis and pulmonary vascular defects.
Keywords: COPD, asthma, lung cancer, fibrosis, pulmonary hypertension, smooth muscle, fibroblast, airway epithelium
Current Molecular Medicine
Title: Caveolae and Caveolins in the Respiratory System
Volume: 8 Issue: 8
Author(s): Reinoud Gosens, Mark Mutawe, Sarah Martin, Sujata Basu, Sophie T. Bos, Thai Tran and Andrew J. Halayko
Affiliation:
Keywords: COPD, asthma, lung cancer, fibrosis, pulmonary hypertension, smooth muscle, fibroblast, airway epithelium
Abstract: Caveolae are flask-shaped invaginations of the plasma membrane that are present in most structural cells. They owe their characteristic Ω-shape to complexes of unique proteins, the caveolins, which indirectly tether cholesterol and sphingolipid-enriched membrane microdomains to the cytoskeleton. Caveolins possess a unique scaffolding domain that anchors receptors, ion channels, second messenger producing enzymes, and effector kinases, thereby sequestering them to caveolae, and modulating cellular signaling and vesicular transport. The lungs express numerous caveolae and high levels of caveolins; therefore they likely play an important role in lung physiology. Indeed, recent and ongoing studies indicate important roles for caveolae and caveolins in the airway epithelium, airway smooth muscle, airway fibroblasts, airway inflammatory cells and the pulmonary vasculature. We review the role of caveolae and caveolins in lung cells and discuss their involvement in cellular signaling associated with asthma, COPD, lung cancer, idiopathic pulmonary fibrosis and pulmonary vascular defects.
Export Options
About this article
Cite this article as:
Gosens Reinoud, Mutawe Mark, Martin Sarah, Basu Sujata, Bos T. Sophie, Tran Thai and Halayko J. Andrew, Caveolae and Caveolins in the Respiratory System, Current Molecular Medicine 2008; 8 (8) . https://dx.doi.org/10.2174/156652408786733720
DOI https://dx.doi.org/10.2174/156652408786733720 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functionalized Biogenic Nanoparticles for Use in Emerging Biomedical Applications: A Review
Current Nanomaterials Click Synthesis, Anticancer Activity and Molecular Docking Studies on Pyridazinone Scaffolds
Current Organic Chemistry The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems
Current Drug Metabolism Aetiology, Diagnosis and Treatment of Hydrops Foetalis
Current Pediatric Reviews Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Current Pharmaceutical Biotechnology Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism Volatile Organic Compounds Trapping from Gaseous Samples on the Basis of Co-Liquefaction with Organic Solvent for Gas Chromatographic Analysis
Current Analytical Chemistry Radioprotective Gene Therapy
Current Gene Therapy Thermosensitive Liposomes in Cancer Therapy
Recent Patents on Biomedical Engineering (Discontinued) Cancer “Stemness”- Regulating MicroRNAs: Role, Mechanisms and Therapeutic Potential
Current Drug Targets Regulation of miRNA Processing and miRNA Mediated Gene Repression in Cancer
MicroRNA Diabetic Retinopathy: Current and New Treatment Options
Current Diabetes Reviews Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Current Molecular Pharmacology Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
Anti-Cancer Agents in Medicinal Chemistry High Throughput Screening for Protein Kinase Inhibitors
Combinatorial Chemistry & High Throughput Screening Current Concepts on Cardiovascular Stent Devices
Mini-Reviews in Medicinal Chemistry The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design Inhibitors of 11β-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol
Current Medicinal Chemistry